Quick Answer
Spyre Therapeutics, Inc. reported Total Assets of $777.78 million for fiscal year 2025.
Spyre Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $777.78M | +27.8% |
| 2024 | $608.48M | +78.0% |
| 2023 | $341.86M | +380.5% |
| 2022 | $71.14M | -35.3% |
| 2021 | $109.93M | -32.0% |
| 2020 | $161.62M | +94.3% |
| 2019 | $83.18M | +7.0% |
| 2018 | $77.74M | +38.6% |
| 2017 | $56.08M | -16.4% |
| 2016 | $67.06M | +73.5% |
| 2015 | $38.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $504.60M | +19.8% | -6.4% |
| June 30, 2025 | $538.83M | +23.6% | -5.4% |
| March 31, 2025 | $569.78M | +16.9% | -6.4% |
| December 31, 2024 | $608.48M | +78.0% | +44.5% |
| September 30, 2024 | $421.09M | +103.2% | -3.4% |
| June 30, 2024 | $436.07M | +79.1% | -10.6% |
| March 31, 2024 | $487.60M | +829.6% | +42.6% |
| December 31, 2023 | $341.86M | +380.5% | +64.9% |
- Spyre Therapeutics, Inc. showed an increase of +27.8% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Spyre Therapeutics, Inc.’s total assets has grown by 1912.2% (from $38.65 million to $777.78 million).
- The most recent figure is from Spyre Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: